One-Year Outcomes of Prenatal Exposure to MDMA and Other Recreational Drugs
Lynn T. Singer, David G. Moore, Meeyoung O. Min, Julia Goodwin, John Turner, Sarah Fulton, A. C. Parrott
PEDIATRICS August 21, 2012 DOI: 10.1542/peds.2012-0666 via OpenAlex
Summary
AI-generated from the abstractHeavier prenatal exposure to MDMA (ecstasy) predicted poorer mental and motor development in 12-month-old infants, with motor delays appearing in a dose-dependent manner. Lighter-exposed infants were comparable to nonexposed infants. No effects were found on language, emotional regulation, or parenting stress. The study involved 96 women in the United Kingdom—28 who used MDMA during pregnancy and 68 who did not—and used standardized developmental assessments.
Study at a glance
| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 96 |
| Population | Women in the United Kingdom, primarily middle class with some university education, in stable partner relationships, and polydrug users |
| Duration | Pregnancy through 12 months postpartum |
| Topics | MDMA |
| Keywords | Medicine Psychomotor learning Psychiatry |
| Citations | 49 |
| Key finding | Heavier prenatal MDMA exposure predicted poorer infant mental and motor development at 12 months in a dose-dependent manner, with motor development specifically delayed in heavily exposed infants. |
Abstract
OBJECTIVE: A widely used illicit recreational drug among young adults, 3,4-methylenedioxymethamphetamine (MDMA) or ecstasy, is an indirect monoaminergic agonist/reuptake inhibitor affecting the serotonin system. Preclinical studies found prenatal exposure related to long-term learning and memory impairments. There are no studies of sequelae of prenatal MDMA exposure in humans, despite potential harmful effects to the fetus. METHODS: A total of 96 women in the United Kingdom (28 MDMA users; 68 non-MDMA) were interviewed about recreational drug use during pregnancy. Their infants were seen at 12 months using standardized assessments of cognitive, language, and motor development (Preschool Language Scale, Bayley Mental and Motor Development and Behavior Rating Scales [Mental Development Index, Psychomotor Development Index, Behavioral Rating Scale]). Mothers completed the Child Domain Scale of the Parenting Stress Index, The Home Observation of the Environment Scale (in interview), the Brief Symptom Inventory, and the Drug Abuse Screening Test. Women were primarily middle class with some university education, in stable partner relationships, and polydrug users. MDMA and other drug effects were assessed through multiple regression analyses controlling for confounding variables, and analysis of covariance comparing heavier versus lighter and nonexposed groups. RESULTS: Amount of prenatal MDMA exposure predicted poorer infant mental and motor development at 12 months in a dose-dependent manner. Heavily exposed infants were delayed in motor development. Lighter-exposed infants were comparable to nonexposed infants. There were no effects on language, emotional regulation, or parenting stress. CONCLUSIONS: Findings document persistent neurotoxic effects of heavier prenatal MDMA exposure on motor development through the first year of life.